Rationale and Design of SCOT-HEART 2 Trial: CT Angiography for the Prevention of Myocardial Infarction

Area of Science:

• Cardiology
• Medical Imaging
• Preventative Medicine

Background:

• Coronary artery disease (CAD) is a leading global cause of death.
• Current CAD prevention relies on risk scoring, lacking proven efficacy from randomized trials.
• Previous imaging for prevention focused on indirect measures like carotid intima-media thickening or coronary artery calcification.

Purpose of the Study:

• To evaluate if computed tomography (CT) coronary angiography improves upon cardiovascular risk scoring for guiding primary preventative therapies.
• To determine if CT coronary angiography reduces the risk of myocardial infarction compared to risk scoring.

Main Methods:

• The SCOT-HEART 2 (Scottish Computed Tomography of the Heart 2) trial design is based on recent findings.
• Recent trials showed CT coronary angiography led to increased preventative therapy and fewer cardiac events.

Main Results:

• Patients identified with CAD via CT coronary angiography were more likely to receive preventative therapy.
• These patients also experienced lower rates of cardiac events.

Conclusions:

• CT coronary angiography shows promise in guiding preventative therapy for coronary artery disease.
• This imaging technique may be more effective than risk scoring in reducing myocardial infarction risk.